Endocrine Testing Market Size, Share & Trends Analysis Report By Test Type (hCG, FSH, TSH, Insulin), By Technology (Mass Spectroscopy, Immunoassay), By End-user, And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within 3 Business Days
Endocrine Testing Market Growth & Trends
The global endocrine testing market is expected to reach USD 4.79 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to witness a CAGR of 8.31% from 2022 to 2030. The growing prevalence of life style diseases such as obesity coupled with diabetes & thyroid among the adult as well as the geriatric population is driving the need for endocrine testing. The routine endocrine testing in individuals will help in overall maintenance of health and thus this awareness of better health is significantly contributing to the global endocrine testing market growth.
As per the statistics by WHO, more than 39 million children in 2020 who were under the age of 5 were overweight or obese. The sedentary life along with unhealthy diet choices have contributed to obesity as well as diabetes in the general population. This occurrence of diseased conditions has also prompted many researches into the metabolic functions and related hormonal disorders.
Funding from government and private organizations has also driven the scientific community. For instance, the NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases) by NIH drives many sponsored research programs towards improving health by better understanding of diseases. One such effort by NIDDK was the mid-atlantic symposium conducted in September 2022 for diabetes and obesity research. This will enable scientific knowledge exchange and interactions and allow collaboration at the regional level. Such initiatives will drive the understanding of endocrine function in the human body and will further enable the endocrine testing market growth.
The lack of awareness in underdeveloped and developing countries is anticipated to slow the growth of endocrine testing market. The developing health care settings and absence of reimbursement models restrain the individuals in these regions to undergo routine endocrine testing. However, with the growing consciousness of a healthy system during the COVID-19 pandemic is expected to upswing the testing frequency for these countries as well.
The outbreak of COVID-19 has created lucrative opportunities for the application of endocrine testing. COVID-19 infections cause a systemic disease that injures many organs. Therefore, these patients have many metabolic and hormonal disturbances that led to an increase in the number of endocrine research. For instance, in March 2021, Endocrine society members sanctioned USD 10 billion to support COVID-19 research to identify and understand the short and long-term COVID-19 effects on the endocrine system. Similarly, in September 2020, The American Diabetes Association invested USD 1 million to fund various research projects for investigating the link between diabetes and COVID-19. Thus, it will increase the demand and further boost market growth.
In addition, the limitation of movement and restrictions due to the lockdown encouraged the digital platform for medical consultation and at home sample collection services as well. The availability of point-of-care devices and kits for the detection of hormone levels at home is also driving the overall growth of endocrine testing market.
The market players are also expanding their regional presence due to various factors that are anticipated to grow the endocrine testing market. Collaboration, partnerships and global expansions are some of the business strategies by the key players to drive revenue generation. For instance, in February 2022 Laboratory Corporation of America Holdings (Labcorp) announced opening of a new laboratory in Indiana, U.S. The new diagnostics business in South Bend, Indiana will enhance the company’s services and make their offerings accessible to both patients as well as physicians in this region.
Endocrine Testing Market Report Highlights
Endocrine Testing Market Growth & Trends
The global endocrine testing market is expected to reach USD 4.79 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to witness a CAGR of 8.31% from 2022 to 2030. The growing prevalence of life style diseases such as obesity coupled with diabetes & thyroid among the adult as well as the geriatric population is driving the need for endocrine testing. The routine endocrine testing in individuals will help in overall maintenance of health and thus this awareness of better health is significantly contributing to the global endocrine testing market growth.
As per the statistics by WHO, more than 39 million children in 2020 who were under the age of 5 were overweight or obese. The sedentary life along with unhealthy diet choices have contributed to obesity as well as diabetes in the general population. This occurrence of diseased conditions has also prompted many researches into the metabolic functions and related hormonal disorders.
Funding from government and private organizations has also driven the scientific community. For instance, the NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases) by NIH drives many sponsored research programs towards improving health by better understanding of diseases. One such effort by NIDDK was the mid-atlantic symposium conducted in September 2022 for diabetes and obesity research. This will enable scientific knowledge exchange and interactions and allow collaboration at the regional level. Such initiatives will drive the understanding of endocrine function in the human body and will further enable the endocrine testing market growth.
The lack of awareness in underdeveloped and developing countries is anticipated to slow the growth of endocrine testing market. The developing health care settings and absence of reimbursement models restrain the individuals in these regions to undergo routine endocrine testing. However, with the growing consciousness of a healthy system during the COVID-19 pandemic is expected to upswing the testing frequency for these countries as well.
The outbreak of COVID-19 has created lucrative opportunities for the application of endocrine testing. COVID-19 infections cause a systemic disease that injures many organs. Therefore, these patients have many metabolic and hormonal disturbances that led to an increase in the number of endocrine research. For instance, in March 2021, Endocrine society members sanctioned USD 10 billion to support COVID-19 research to identify and understand the short and long-term COVID-19 effects on the endocrine system. Similarly, in September 2020, The American Diabetes Association invested USD 1 million to fund various research projects for investigating the link between diabetes and COVID-19. Thus, it will increase the demand and further boost market growth.
In addition, the limitation of movement and restrictions due to the lockdown encouraged the digital platform for medical consultation and at home sample collection services as well. The availability of point-of-care devices and kits for the detection of hormone levels at home is also driving the overall growth of endocrine testing market.
The market players are also expanding their regional presence due to various factors that are anticipated to grow the endocrine testing market. Collaboration, partnerships and global expansions are some of the business strategies by the key players to drive revenue generation. For instance, in February 2022 Laboratory Corporation of America Holdings (Labcorp) announced opening of a new laboratory in Indiana, U.S. The new diagnostics business in South Bend, Indiana will enhance the company’s services and make their offerings accessible to both patients as well as physicians in this region.
Endocrine Testing Market Report Highlights
- By test type, the human Chorionic Gonadotropin (hCG) hormone testing accounted for the largest share in 2021, driven by the presence of self-test kits at pharmacy stores, along with tests in laboratories or hospitals for quantitative evaluation. Moreover, the frequency of testing during different weeks of pregnancy and high number of fertile female population are also the contributing factors.
- By technology, immunoassay dominated the 2021 market, owing to the presence of instruments by key players which uses immunoassay-based detection techniques. The large number of instruments and test panels which rely on immunoassay technology, drives the endocrine testing market growth.
- By end-user, commercial laboratories contributed majorly to the revenue generation in 2021. The feasibility & availability of variety of testing panels for endocrinology and reproductive functions, services like at home collection and presence of digital platforms led to the increased segment share.
- North America had the highest revenue generated in 2021 for endocrine testing market. This is attributed to the vast presence of thyroid disorders, diabetes and obesity within the US population. Additionally, developed healthcare and increased spending pattern in this region also led to higher revenue generation.
CHAPTER 1 RESEARCH METHODOLOGY
1.1 Market Segmentation & Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 List of Secondary Sources
1.10 List of Primary Sources
1.11 Objectives
1.11.1 Objective
1.11.2 Objective
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outllook
2.2 Market Summary
CHAPTER 3 MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Trends & Outlook
3.2 Market Segmentation And Scope
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Growing prevalence of diabetes, obese and geriatric population
3.3.1.2 Rising demand of home health care and awareness of routine testing
3.3.1.3 Development of technologies for endocrine testing
3.3.1.4 Increasing investments in research activities for disease understanding
3.3.2 Market Restraint Analysis
3.3.2.1 Dearth of trained professionals
3.3.3 Market Opportunity Analysis
3.3.2.1 Development And Advancement In Detection Technology
3.4 Business Environment Analysis Tools
3.4.1 Swot Analysis, By Pest
3.4.2 Porter’s Five Forces Analysis
3.5 Penetration & Growth Prospect Mapping of Technology, 2021
3.6 Endocrine Testing Market: COVID-19 Impact Analysis
CHAPTER 4 TEST TYPE SEGMENT ANALYSIS
4.1 Endocrine Testing Market: Test Type Movement Analysis
4.2 Estradiol (E2) test
4.2.1 Global Estradiol Test Market, 2018 - 2030 (USD Million)
4.3 Follicle Stimulating Hormone (FSH) Test
4.3.1 Global Follicle Stimulating Hormone Test Market, 2018 - 2030 (USD Million)
4.4 Human Chorionic Gonadotropin (HCG) Hormone Test
4.4.1 Global Human Chorionic Gonadotropin (HCG) Hormone Test Market, 2018 - 2030 (USD Million)
4.5 Luteinizing Hormone (LH) Test
4.5.1 Global Luteinizing Hormone (LH) Test Market, 2018 - 2030 (USD Million)
4.6 Dehydroepiandrosterone Sulfate (DHEAS) Test
4.6.1 Global Dehydroepiandrosterone Sulfate (DHEAS) Test Market, 2018 - 2030 (USD Million)
4.7 Progesterone Test
4.7.1 Global Progesterone Test Market, 2018 - 2030 (USD Million)
4.8 Testosterone Test
4.8.1 Global Testosterone Test Market, 2018 - 2030 (USD Million)
4.9 Thyroid Stimulating Hormone (TSH) Test
4.9.1 Global Thyroid Stimulating Hormone (TSH) Test Market, 2018 - 2030 (USD Million)
4.10 Prolactin Test
4.10.1 Global Prolactin Test Market, 2018 - 2030 (USD Million)
4.11 Cortisol Test
4.11.1 Global Cortisol Test Market, 2018 - 2030 (USD Million)
4.12 Insulin Test
4.12.1 Global Insulin Test Market, 2018 - 2030 (USD Million)
4.13 Others
4.13.1 Global Other Tests Market, 2018 - 2030 (USD Million)
CHAPTER 5 TECHNOLOGY SEGMENT ANALYSIS
5.1 Endocrine Testing Market: Technology Movement Analysis
5.2 Mass Spectroscopy
5.2.1 Global Mass Spectroscopy Market, 2018 - 2030 (USD Million)
5.3 Immunoassay
5.3.1 Global Immunoassay Market, 2018 - 2030 (USD Million)
5.4 Chromatography
5.4.1 Global Chromatography Market, 2018 - 2030 (USD Million)
5.5 Nucleic Acid Based
5.5.1 Global Nucleic Acid Based Market, 2018 - 2030 (USD Million)
CHAPTER 6 END-USER SEGMENT ANALYSIS
6.1 Endocrine Testing Analysis Market: End-User Movement Analysis
6.2 Hospitals
6.2.1 Global Hospitals Market, 2018 - 2030 (USD Million)
6.3 Commercial Laboratories
6.3.1 Global Commercial Laboratories Market, 2018 - 2030 (USD Million)
6.4 Ambulatory Care Centers
6.4.1 Global Ambulatory Care Centers Market, 2018 - 2030 (USD Million)
6.5 Others
6.5.1 Global Other End-Users, 2018 - 2030 (USD Million)
CHAPTER 7 REGIONAL OUTLOOK
7.1 Endocrine Testing Market: Regional Movement Analysis
7.2 North America
7.2.1 North America Endocrine Testing Market, 2018 - 2030 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. Endocrine Testing Market, 2018 - 2030 (USD Million)
7.2.3 Canada
7.2.3.1 Canada Endocrine Testing Market, 2018 - 2030 (USD Million)
7.3 Europe
7.3.1 Europe Endocrine Testing Market, 2018 - 2030 (USD Million)
7.3.2 Germany
7.3.2.1 Germany Endocrine Testing Market, 2018 - 2030 (USD Million)
7.3.3 UK
7.3.3.1 UK Endocrine Testing Market, 2018 - 2030 (USD Million)
7.3.4 France
7.3.4.1 France Endocrine Testing Market, 2018 - 2030 (USD Million)
7.3.5 Italy
7.3.5.1 Italy Endocrine Testing Market, 2018 - 2030 (USD Million)
7.3.6 Spain
7.3.6.1 Spain Endocrine Testing Market, 2018 - 2030 (USD Million)
7.4 Asia Pacific (APAC)
7.4.1 Asia Pacific Endocrine Testing Market, 2018 - 2030 (USD Million)
7.4.2 China
7.4.2.1 China Endocrine Testing Market, 2018 - 2030 (USD Million)
7.4.3 Japan
7.4.3.1 Japan Endocrine Testing Market, 2018 - 2030 (USD Million)
7.4.4 India
7.4.4.1 India Endocrine Testing Market, 2018 - 2030 (USD Million)
7.4.5 South Korea
7.4.5.1 South Korea Endocrine Testing Market, 2018 - 2030 (USD Million)
7.4.6 Australia
7.4.6.1 Australia Endocrine Testing Market, 2018 - 2030 (USD Million)
7.5 Latin America (LATAM)
7.5.1 Latin America Endocrine Testing Market, 2018 - 2030 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil Endocrine Testing Market, 2018 - 2030 (USD Million)
7.5.3 Mexico
7.5.3.1 Mexico Endocrine Testing Market, 2018 - 2030 (USD Million)
7.6 Middle East And Africa (MEA)
7.6.1 Middle East And Africa Endocrine Testing Market, 2018 - 2030 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa Endocrine Testing Market, 2018 - 2030 (USD Million)
7.6.3 UAE
7.6.3.1 UAE Endocrine Testing Market, 2018 - 2030 (USD Million)
7.6.4 Saudi Arabia
7.6.4.1 Saudi Arabia endocrine testing market, 2018 - 2030 (USD Million)
CHAPTER 8 COMPANY PROFILES
8.1 Strategy Framework
8.2 Market Participation Categorization
8.3 Company Profiles
8.3.1 ABBOTT LABORATORIES
8.3.1.1 Company overview
8.3.1.2 Financial performance
8.3.1.3 Product benchmarking
8.3.1.4 Strategic initiatives
8.3.2 AGILENT TECHNOLOGIES INC.
8.3.2.1 Company overview
8.3.2.2 Financial performance
8.3.2.3 Product benchmarking
8.3.2.4 Strategic initiatives
8.3.3 BIO-RAD LABORATORIES, INC.
8.3.3.1 Company overview
8.3.3.2 Financial performance
8.3.3.3 Product benchmarking
8.3.3.4 Strategic initiatives
8.3.4 BIOMERIEUX SA
8.3.4.1 Company overview
8.3.4.2 Financial performance
8.3.4.3 Product benchmarking
8.3.4.4 Strategic initiatives
8.3.5 DIASORIN S.P.A.
8.3.5.1 Company overview
8.3.5.2 Financial performance
8.3.5.3 Product benchmarking
8.3.5.4 Strategic initiatives
8.3.6 F. HOFFMANN-LA ROCHE LTD.
8.3.6.1 Company overview
8.3.6.2 Financial performance
8.3.6.3 Product benchmarking
8.3.6.4 Strategic initiatives
8.3.7 LABORATORY CORPORATION OF AMERICA HOLDINGS
8.3.7.1 Company overview
8.3.7.2 Financial performance
8.3.7.3 Product benchmarking
8.3.7.4 Strategic initiatives
8.3.8 ORTHO CLINICAL DIAGNOSTICS
8.3.8.1 Company overview
8.3.8.2 Financial performance
8.3.8.3 Product benchmarking
8.3.8.4 Strategic initiatives
8.3.9 QUEST DIAGNOSTICS INCORPORATED
8.3.9.1 Company overview
8.3.9.2 Financial performance
8.3.9.3 Product benchmarking
8.3.9.4 Strategic initiatives
8.3.10 DANAHER
8.3.10.1 Company overview
8.3.10.1.1 AB SCIEX
8.3.10.2 Financial performance
8.3.10.3 Product benchmarking
8.3.10.4 Strategic initiatives
1.1 Market Segmentation & Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 List of Secondary Sources
1.10 List of Primary Sources
1.11 Objectives
1.11.1 Objective
1.11.2 Objective
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outllook
2.2 Market Summary
CHAPTER 3 MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Trends & Outlook
3.2 Market Segmentation And Scope
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Growing prevalence of diabetes, obese and geriatric population
3.3.1.2 Rising demand of home health care and awareness of routine testing
3.3.1.3 Development of technologies for endocrine testing
3.3.1.4 Increasing investments in research activities for disease understanding
3.3.2 Market Restraint Analysis
3.3.2.1 Dearth of trained professionals
3.3.3 Market Opportunity Analysis
3.3.2.1 Development And Advancement In Detection Technology
3.4 Business Environment Analysis Tools
3.4.1 Swot Analysis, By Pest
3.4.2 Porter’s Five Forces Analysis
3.5 Penetration & Growth Prospect Mapping of Technology, 2021
3.6 Endocrine Testing Market: COVID-19 Impact Analysis
CHAPTER 4 TEST TYPE SEGMENT ANALYSIS
4.1 Endocrine Testing Market: Test Type Movement Analysis
4.2 Estradiol (E2) test
4.2.1 Global Estradiol Test Market, 2018 - 2030 (USD Million)
4.3 Follicle Stimulating Hormone (FSH) Test
4.3.1 Global Follicle Stimulating Hormone Test Market, 2018 - 2030 (USD Million)
4.4 Human Chorionic Gonadotropin (HCG) Hormone Test
4.4.1 Global Human Chorionic Gonadotropin (HCG) Hormone Test Market, 2018 - 2030 (USD Million)
4.5 Luteinizing Hormone (LH) Test
4.5.1 Global Luteinizing Hormone (LH) Test Market, 2018 - 2030 (USD Million)
4.6 Dehydroepiandrosterone Sulfate (DHEAS) Test
4.6.1 Global Dehydroepiandrosterone Sulfate (DHEAS) Test Market, 2018 - 2030 (USD Million)
4.7 Progesterone Test
4.7.1 Global Progesterone Test Market, 2018 - 2030 (USD Million)
4.8 Testosterone Test
4.8.1 Global Testosterone Test Market, 2018 - 2030 (USD Million)
4.9 Thyroid Stimulating Hormone (TSH) Test
4.9.1 Global Thyroid Stimulating Hormone (TSH) Test Market, 2018 - 2030 (USD Million)
4.10 Prolactin Test
4.10.1 Global Prolactin Test Market, 2018 - 2030 (USD Million)
4.11 Cortisol Test
4.11.1 Global Cortisol Test Market, 2018 - 2030 (USD Million)
4.12 Insulin Test
4.12.1 Global Insulin Test Market, 2018 - 2030 (USD Million)
4.13 Others
4.13.1 Global Other Tests Market, 2018 - 2030 (USD Million)
CHAPTER 5 TECHNOLOGY SEGMENT ANALYSIS
5.1 Endocrine Testing Market: Technology Movement Analysis
5.2 Mass Spectroscopy
5.2.1 Global Mass Spectroscopy Market, 2018 - 2030 (USD Million)
5.3 Immunoassay
5.3.1 Global Immunoassay Market, 2018 - 2030 (USD Million)
5.4 Chromatography
5.4.1 Global Chromatography Market, 2018 - 2030 (USD Million)
5.5 Nucleic Acid Based
5.5.1 Global Nucleic Acid Based Market, 2018 - 2030 (USD Million)
CHAPTER 6 END-USER SEGMENT ANALYSIS
6.1 Endocrine Testing Analysis Market: End-User Movement Analysis
6.2 Hospitals
6.2.1 Global Hospitals Market, 2018 - 2030 (USD Million)
6.3 Commercial Laboratories
6.3.1 Global Commercial Laboratories Market, 2018 - 2030 (USD Million)
6.4 Ambulatory Care Centers
6.4.1 Global Ambulatory Care Centers Market, 2018 - 2030 (USD Million)
6.5 Others
6.5.1 Global Other End-Users, 2018 - 2030 (USD Million)
CHAPTER 7 REGIONAL OUTLOOK
7.1 Endocrine Testing Market: Regional Movement Analysis
7.2 North America
7.2.1 North America Endocrine Testing Market, 2018 - 2030 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. Endocrine Testing Market, 2018 - 2030 (USD Million)
7.2.3 Canada
7.2.3.1 Canada Endocrine Testing Market, 2018 - 2030 (USD Million)
7.3 Europe
7.3.1 Europe Endocrine Testing Market, 2018 - 2030 (USD Million)
7.3.2 Germany
7.3.2.1 Germany Endocrine Testing Market, 2018 - 2030 (USD Million)
7.3.3 UK
7.3.3.1 UK Endocrine Testing Market, 2018 - 2030 (USD Million)
7.3.4 France
7.3.4.1 France Endocrine Testing Market, 2018 - 2030 (USD Million)
7.3.5 Italy
7.3.5.1 Italy Endocrine Testing Market, 2018 - 2030 (USD Million)
7.3.6 Spain
7.3.6.1 Spain Endocrine Testing Market, 2018 - 2030 (USD Million)
7.4 Asia Pacific (APAC)
7.4.1 Asia Pacific Endocrine Testing Market, 2018 - 2030 (USD Million)
7.4.2 China
7.4.2.1 China Endocrine Testing Market, 2018 - 2030 (USD Million)
7.4.3 Japan
7.4.3.1 Japan Endocrine Testing Market, 2018 - 2030 (USD Million)
7.4.4 India
7.4.4.1 India Endocrine Testing Market, 2018 - 2030 (USD Million)
7.4.5 South Korea
7.4.5.1 South Korea Endocrine Testing Market, 2018 - 2030 (USD Million)
7.4.6 Australia
7.4.6.1 Australia Endocrine Testing Market, 2018 - 2030 (USD Million)
7.5 Latin America (LATAM)
7.5.1 Latin America Endocrine Testing Market, 2018 - 2030 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil Endocrine Testing Market, 2018 - 2030 (USD Million)
7.5.3 Mexico
7.5.3.1 Mexico Endocrine Testing Market, 2018 - 2030 (USD Million)
7.6 Middle East And Africa (MEA)
7.6.1 Middle East And Africa Endocrine Testing Market, 2018 - 2030 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa Endocrine Testing Market, 2018 - 2030 (USD Million)
7.6.3 UAE
7.6.3.1 UAE Endocrine Testing Market, 2018 - 2030 (USD Million)
7.6.4 Saudi Arabia
7.6.4.1 Saudi Arabia endocrine testing market, 2018 - 2030 (USD Million)
CHAPTER 8 COMPANY PROFILES
8.1 Strategy Framework
8.2 Market Participation Categorization
8.3 Company Profiles
8.3.1 ABBOTT LABORATORIES
8.3.1.1 Company overview
8.3.1.2 Financial performance
8.3.1.3 Product benchmarking
8.3.1.4 Strategic initiatives
8.3.2 AGILENT TECHNOLOGIES INC.
8.3.2.1 Company overview
8.3.2.2 Financial performance
8.3.2.3 Product benchmarking
8.3.2.4 Strategic initiatives
8.3.3 BIO-RAD LABORATORIES, INC.
8.3.3.1 Company overview
8.3.3.2 Financial performance
8.3.3.3 Product benchmarking
8.3.3.4 Strategic initiatives
8.3.4 BIOMERIEUX SA
8.3.4.1 Company overview
8.3.4.2 Financial performance
8.3.4.3 Product benchmarking
8.3.4.4 Strategic initiatives
8.3.5 DIASORIN S.P.A.
8.3.5.1 Company overview
8.3.5.2 Financial performance
8.3.5.3 Product benchmarking
8.3.5.4 Strategic initiatives
8.3.6 F. HOFFMANN-LA ROCHE LTD.
8.3.6.1 Company overview
8.3.6.2 Financial performance
8.3.6.3 Product benchmarking
8.3.6.4 Strategic initiatives
8.3.7 LABORATORY CORPORATION OF AMERICA HOLDINGS
8.3.7.1 Company overview
8.3.7.2 Financial performance
8.3.7.3 Product benchmarking
8.3.7.4 Strategic initiatives
8.3.8 ORTHO CLINICAL DIAGNOSTICS
8.3.8.1 Company overview
8.3.8.2 Financial performance
8.3.8.3 Product benchmarking
8.3.8.4 Strategic initiatives
8.3.9 QUEST DIAGNOSTICS INCORPORATED
8.3.9.1 Company overview
8.3.9.2 Financial performance
8.3.9.3 Product benchmarking
8.3.9.4 Strategic initiatives
8.3.10 DANAHER
8.3.10.1 Company overview
8.3.10.1.1 AB SCIEX
8.3.10.2 Financial performance
8.3.10.3 Product benchmarking
8.3.10.4 Strategic initiatives
LIST OF TABLES
TABLE 1 List of secondary sources
TABLE 2 Global endocrine testing market, by test type, 2018 - 2030 (USD Million)
TABLE 3 Global endocrine testing market, by technology, 2018 - 2030 (USD Million)
TABLE 4 Global endocrine testing market, by end-user, 2018 - 2030 (USD Million)
TABLE 5 North America endocrine testing market, by country, 2018 - 2030 (USD Million)
TABLE 6 North America endocrine testing market, by test type, 2018 - 2030 (USD Million)
TABLE 7 North America endocrine testing market, by technology, 2018 - 2030 (USD Million)
TABLE 8 North America endocrine testing market, by end-user, 2018 - 2030 (USD Million)
TABLE 9 U.S. endocrine testing market, by test type, 2018 - 2030 (USD Million)
TABLE 10 U.S. endocrine testing market, by technology, 2018 - 2030 (USD Million)
TABLE 11 U.S. endocrine testing market, by end-user, 2018 - 2030 (USD Million)
TABLE 12 Canada endocrine testing market, by test type, 2018 - 2030 (USD Million)
TABLE 13 Canada endocrine testing market, by technology, 2018 - 2030 (USD Million)
TABLE 14 Canada endocrine testing market, by end-user, 2018 - 2030 (USD Million)
TABLE 15 Europe endocrine testing market, by country, 2018 - 2030 (USD Million)
TABLE 16 Europe endocrine testing market, by test type, 2018 - 2030 (USD Million)
TABLE 17 Europe endocrine testing market, by technology, 2018 - 2030 (USD Million)
TABLE 18 Europe endocrine testing market, by end-user, 2018 - 2030 (USD Million)
TABLE 19 Germany endocrine testing market, by test type, 2018 - 2030 (USD Million)
TABLE 20 Germany endocrine testing market, by technology, 2018 - 2030 (USD Million)
TABLE 21 Germany endocrine testing market, by end-user, 2018 - 2030 (USD Million)
TABLE 22 UK endocrine testing market, by test type, 2018 - 2030 (USD Million)
TABLE 23 UK endocrine testing market, by technology, 2018 - 2030 (USD Million)
TABLE 24 UK endocrine testing market, by end-user, 2018 - 2030 (USD Million)
TABLE 25 France endocrine testing market, by test type, 2018 - 2030 (USD Million)
TABLE 26 France endocrine testing market, by technology, 2018 - 2030 (USD Million)
TABLE 27 France endocrine testing market, by end-user, 2018 - 2030 (USD Million)
TABLE 28 Italy endocrine testing market, by test type, 2018 - 2030 (USD Million)
TABLE 29 Italy endocrine testing market, by technology, 2018 - 2030 (USD Million)
TABLE 30 Italy endocrine testing market, by end-user, 2018 - 2030 (USD Million)
TABLE 31 Spain endocrine testing market, by test type, 2018 - 2030 (USD Million)
TABLE 32 Spain endocrine testing market, by technology, 2018 - 2030 (USD Million)
TABLE 33 Spain endocrine testing market, by end-user, 2018 - 2030 (USD Million)
TABLE 34 Asia Pacific endocrine testing market, by country, 2018 - 2030 (USD Million)
TABLE 35 Asia Pacific endocrine testing market, by test type, 2018 - 2030 (USD Million)
TABLE 36 Asia Pacific endocrine testing market, by technology, 2018 - 2030 (USD Million)
TABLE 37 Asia Pacific endocrine testing market, by end-user, 2018 - 2030 (USD Million)
TABLE 38 China endocrine testing market, by test type, 2018 - 2030 (USD Million)
TABLE 39 China endocrine testing market, by technology, 2018 - 2030 (USD Million)
TABLE 40 China endocrine testing market, by end-user, 2018 - 2030 (USD Million)
TABLE 41 Japan endocrine testing market, by test type, 2018 - 2030 (USD Million)
TABLE 42 Japan endocrine testing market, by technology, 2018 - 2030 (USD Million)
TABLE 43 Japan endocrine testing market, by end-user, 2018 - 2030 (USD Million)
TABLE 44 India endocrine testing market, by test type, 2018 - 2030 (USD Million)
TABLE 45 India endocrine testing market, by technology, 2018 - 2030 (USD Million)
TABLE 46 India endocrine testing market, by end-user, 2018 - 2030 (USD Million)
TABLE 47 South Korea endocrine testing market, by test type, 2018 - 2030 (USD Million)
TABLE 48 South Korea endocrine testing market, by technology, 2018 - 2030 (USD Million)
TABLE 49 South Korea endocrine testing market, by end-user, 2018 - 2030 (USD Million)
TABLE 50 Australia endocrine testing market, by test type, 2018 - 2030 (USD Million)
TABLE 51 Australia endocrine testing market, by technology, 2018 - 2030 (USD Million)
TABLE 52 Australia endocrine testing market, by end-user, 2018 - 2030 (USD Million)
TABLE 53 Latin America endocrine testing market, by country, 2018 - 2030 (USD Million)
TABLE 54 Latin America endocrine testing market, by test type, 2018 - 2030 (USD Million)
TABLE 55 Latin America endocrine testing market, by technology, 2018 - 2030 (USD Million)
TABLE 56 Latin America endocrine testing market, by end-user, 2018 - 2030 (USD Million)
TABLE 57 Brazil endocrine testing market, by test type, 2018 - 2030 (USD Million)
TABLE 58 Brazil endocrine testing market, by technology, 2018 - 2030 (USD Million)
TABLE 59 Brazil endocrine testing market, by end-user, 2018 - 2030 (USD Million)
TABLE 60 Mexico endocrine testing market, by test type, 2018 - 2030 (USD Million)
TABLE 61 Mexico endocrine testing market, by technology, 2018 - 2030 (USD Million)
TABLE 62 Mexico endocrine testing market, by end-user, 2018 - 2030 (USD Million)
TABLE 63 Middle East & Africa endocrine testing market, by country, 2018 - 2030 (USD Million)
TABLE 64 Middle East & Africa endocrine testing market, by test type, 2018 - 2030 (USD Million)
TABLE 65 Middle East & Africa endocrine testing market, by technology, 2018 - 2030 (USD Million)
TABLE 66 Middle East & Africa endocrine testing market, by end-user, 2018 - 2030 (USD Million)
TABLE 67 South Africa endocrine testing market, by test type, 2018 - 2030 (USD Million)
TABLE 68 South Africa endocrine testing market, by technology, 2018 - 2030 (USD Million)
TABLE 69 South Africa endocrine testing market, by end-user, 2018 - 2030 (USD Million)
TABLE 70 UAE endocrine testing market, by test type, 2018 - 2030 (USD Million)
TABLE 71 UAE endocrine testing market, by technology, 2018 - 2030 (USD Million)
TABLE 72 UAE endocrine testing market, by end-user, 2018 - 2030 (USD Million)
TABLE 73 Saudi Arabia endocrine testing market, by test type, 2018 - 2030 (USD Million)
TABLE 74 Saudi Arabia endocrine testing market, by technology, 2018 - 2030 (USD Million)
TABLE 75 Saudi Arabia endocrine testing market, by end-user, 2018 - 2030 (USD Million)
TABLE 1 List of secondary sources
TABLE 2 Global endocrine testing market, by test type, 2018 - 2030 (USD Million)
TABLE 3 Global endocrine testing market, by technology, 2018 - 2030 (USD Million)
TABLE 4 Global endocrine testing market, by end-user, 2018 - 2030 (USD Million)
TABLE 5 North America endocrine testing market, by country, 2018 - 2030 (USD Million)
TABLE 6 North America endocrine testing market, by test type, 2018 - 2030 (USD Million)
TABLE 7 North America endocrine testing market, by technology, 2018 - 2030 (USD Million)
TABLE 8 North America endocrine testing market, by end-user, 2018 - 2030 (USD Million)
TABLE 9 U.S. endocrine testing market, by test type, 2018 - 2030 (USD Million)
TABLE 10 U.S. endocrine testing market, by technology, 2018 - 2030 (USD Million)
TABLE 11 U.S. endocrine testing market, by end-user, 2018 - 2030 (USD Million)
TABLE 12 Canada endocrine testing market, by test type, 2018 - 2030 (USD Million)
TABLE 13 Canada endocrine testing market, by technology, 2018 - 2030 (USD Million)
TABLE 14 Canada endocrine testing market, by end-user, 2018 - 2030 (USD Million)
TABLE 15 Europe endocrine testing market, by country, 2018 - 2030 (USD Million)
TABLE 16 Europe endocrine testing market, by test type, 2018 - 2030 (USD Million)
TABLE 17 Europe endocrine testing market, by technology, 2018 - 2030 (USD Million)
TABLE 18 Europe endocrine testing market, by end-user, 2018 - 2030 (USD Million)
TABLE 19 Germany endocrine testing market, by test type, 2018 - 2030 (USD Million)
TABLE 20 Germany endocrine testing market, by technology, 2018 - 2030 (USD Million)
TABLE 21 Germany endocrine testing market, by end-user, 2018 - 2030 (USD Million)
TABLE 22 UK endocrine testing market, by test type, 2018 - 2030 (USD Million)
TABLE 23 UK endocrine testing market, by technology, 2018 - 2030 (USD Million)
TABLE 24 UK endocrine testing market, by end-user, 2018 - 2030 (USD Million)
TABLE 25 France endocrine testing market, by test type, 2018 - 2030 (USD Million)
TABLE 26 France endocrine testing market, by technology, 2018 - 2030 (USD Million)
TABLE 27 France endocrine testing market, by end-user, 2018 - 2030 (USD Million)
TABLE 28 Italy endocrine testing market, by test type, 2018 - 2030 (USD Million)
TABLE 29 Italy endocrine testing market, by technology, 2018 - 2030 (USD Million)
TABLE 30 Italy endocrine testing market, by end-user, 2018 - 2030 (USD Million)
TABLE 31 Spain endocrine testing market, by test type, 2018 - 2030 (USD Million)
TABLE 32 Spain endocrine testing market, by technology, 2018 - 2030 (USD Million)
TABLE 33 Spain endocrine testing market, by end-user, 2018 - 2030 (USD Million)
TABLE 34 Asia Pacific endocrine testing market, by country, 2018 - 2030 (USD Million)
TABLE 35 Asia Pacific endocrine testing market, by test type, 2018 - 2030 (USD Million)
TABLE 36 Asia Pacific endocrine testing market, by technology, 2018 - 2030 (USD Million)
TABLE 37 Asia Pacific endocrine testing market, by end-user, 2018 - 2030 (USD Million)
TABLE 38 China endocrine testing market, by test type, 2018 - 2030 (USD Million)
TABLE 39 China endocrine testing market, by technology, 2018 - 2030 (USD Million)
TABLE 40 China endocrine testing market, by end-user, 2018 - 2030 (USD Million)
TABLE 41 Japan endocrine testing market, by test type, 2018 - 2030 (USD Million)
TABLE 42 Japan endocrine testing market, by technology, 2018 - 2030 (USD Million)
TABLE 43 Japan endocrine testing market, by end-user, 2018 - 2030 (USD Million)
TABLE 44 India endocrine testing market, by test type, 2018 - 2030 (USD Million)
TABLE 45 India endocrine testing market, by technology, 2018 - 2030 (USD Million)
TABLE 46 India endocrine testing market, by end-user, 2018 - 2030 (USD Million)
TABLE 47 South Korea endocrine testing market, by test type, 2018 - 2030 (USD Million)
TABLE 48 South Korea endocrine testing market, by technology, 2018 - 2030 (USD Million)
TABLE 49 South Korea endocrine testing market, by end-user, 2018 - 2030 (USD Million)
TABLE 50 Australia endocrine testing market, by test type, 2018 - 2030 (USD Million)
TABLE 51 Australia endocrine testing market, by technology, 2018 - 2030 (USD Million)
TABLE 52 Australia endocrine testing market, by end-user, 2018 - 2030 (USD Million)
TABLE 53 Latin America endocrine testing market, by country, 2018 - 2030 (USD Million)
TABLE 54 Latin America endocrine testing market, by test type, 2018 - 2030 (USD Million)
TABLE 55 Latin America endocrine testing market, by technology, 2018 - 2030 (USD Million)
TABLE 56 Latin America endocrine testing market, by end-user, 2018 - 2030 (USD Million)
TABLE 57 Brazil endocrine testing market, by test type, 2018 - 2030 (USD Million)
TABLE 58 Brazil endocrine testing market, by technology, 2018 - 2030 (USD Million)
TABLE 59 Brazil endocrine testing market, by end-user, 2018 - 2030 (USD Million)
TABLE 60 Mexico endocrine testing market, by test type, 2018 - 2030 (USD Million)
TABLE 61 Mexico endocrine testing market, by technology, 2018 - 2030 (USD Million)
TABLE 62 Mexico endocrine testing market, by end-user, 2018 - 2030 (USD Million)
TABLE 63 Middle East & Africa endocrine testing market, by country, 2018 - 2030 (USD Million)
TABLE 64 Middle East & Africa endocrine testing market, by test type, 2018 - 2030 (USD Million)
TABLE 65 Middle East & Africa endocrine testing market, by technology, 2018 - 2030 (USD Million)
TABLE 66 Middle East & Africa endocrine testing market, by end-user, 2018 - 2030 (USD Million)
TABLE 67 South Africa endocrine testing market, by test type, 2018 - 2030 (USD Million)
TABLE 68 South Africa endocrine testing market, by technology, 2018 - 2030 (USD Million)
TABLE 69 South Africa endocrine testing market, by end-user, 2018 - 2030 (USD Million)
TABLE 70 UAE endocrine testing market, by test type, 2018 - 2030 (USD Million)
TABLE 71 UAE endocrine testing market, by technology, 2018 - 2030 (USD Million)
TABLE 72 UAE endocrine testing market, by end-user, 2018 - 2030 (USD Million)
TABLE 73 Saudi Arabia endocrine testing market, by test type, 2018 - 2030 (USD Million)
TABLE 74 Saudi Arabia endocrine testing market, by technology, 2018 - 2030 (USD Million)
TABLE 75 Saudi Arabia endocrine testing market, by end-user, 2018 - 2030 (USD Million)
LIST OF FIGURES
FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain-based sizing & forecasting
FIG. 6 Market formulation & validation
FIG. 7 Endocrine testing, market segmentation
FIG. 8 Market driver relevance analysis (Current & Future Impact)
FIG. 9 Market restraint relevance analysis (Current & Future Impact)
FIG. 10 Penetration & growth prospect mapping
FIG. 11 SWOT analysis, by factor (Political & Legal, Economic and Technological)
FIG. 12 Porter’s five forces analysis
FIG. 13 Market penetration vs growth prospect mapping, 2021
FIG. 14 Endocrine testing market test type outlook: Key takeaways
FIG. 15 Test type movement analysis, 2021 & 2030
FIG. 16 Global endocrine testing market, for Estradiol (E2) Test 2018 - 2030 (USD Million)
FIG. 17 Global endocrine testing market, for FSH test 2018 - 2030 (USD Million)
FIG. 18 Global endocrine testing market, for hCG test 2018 - 2030 (USD Million)
FIG. 19 Global endocrine testing market, for LH test 2018 - 2030 (USD Million)
FIG. 20 Global endocrine testing market, for DHEAS test 2018 - 2030 (USD Million)
FIG. 21 Global endocrine testing market, for progesterone test 2018 - 2030 (USD Million)
FIG. 22 Global endocrine testing market, for testerone test 2018 - 2030 (USD Million)
FIG. 23 Global endocrine testing market, for TSH test 2018 - 2030 (USD Million)
FIG. 24 Global endocrine testing market, for prolactin test 2018 - 2030 (USD Million)
FIG. 25 Global endocrine testing market, for cortisol test 2018 - 2030 (USD Million)
FIG. 26 Global endocrine testing market, for insulin test 2018 - 2030 (USD Million)
FIG. 27 Global endocrine testing market, for others 2018 - 2030 (USD Million)
FIG. 28 Endocrine testing market technology outlook: Key takeaways
FIG. 29 Technology movement analysis, 2021 & 2030
FIG. 30 Global endocrine testing market, for mass spectroscopy 2018 - 2030 (USD Million)
FIG. 31 Global endocrine testing market, for immunoassay 2018 - 2030 (USD Million)
FIG. 32 Global endocrine testing market, for chromatography 2018 - 2030 (USD Million)
FIG. 33 Global endocrine testing market, for nucleic acid based 2018 - 2030 (USD Million)
FIG. 34 Endocrine testing market end-users outlook: Key takeaways
FIG. 35 End-users movement analysis, 2021 & 2030
FIG. 36 Global endocrine testing market, for hospitals 2018 - 2030 (USD Million)
FIG. 37 Global endocrine testing market, for commercial laboratories 2018 - 2030 (USD Million)
FIG. 38 Global endocrine testing market, for ambulatory care centers 2018 - 2030 (USD Million)
FIG. 39 Global endocrine testing market, for others 2018 - 2030 (USD Million)
FIG. 40 Endocrine testing market regional outlook: Key takeaways
FIG. 41 Regional movement analysis, 2021 & 2030
FIG. 42 North America endocrine testing market, 2018 - 2030 (USD Million)
FIG. 43 U.S. endocrine testing market, 2018 - 2030 (USD Million)
FIG. 44 Canada endocrine testing market, 2018 - 2030 (USD Million)
FIG. 45 Europe endocrine testing market, 2018 - 2030 (USD Million)
FIG. 46 Germany endocrine testing market, 2018 - 2030 (USD Million)
FIG. 47 UK endocrine testing market, 2018 - 2030 (USD Million)
FIG. 48 France endocrine testing market, 2018 - 2030 (USD Million)
FIG. 49 Italy endocrine testing market, 2018 - 2030 (USD Million)
FIG. 50 Spain endocrine testing market, 2018 - 2030 (USD Million)
FIG. 51 Asia Pacific endocrine testing market, 2018 - 2030 (USD Million)
FIG. 52 China endocrine testing market, 2018 - 2030 (USD Million)
FIG. 53 Japan endocrine testing market, 2018 - 2030 (USD Million)
FIG. 54 India endocrine testing market, 2018 - 2030 (USD Million)
FIG. 55 South Korea endocrine testing market, 2018 - 2030 (USD Million)
FIG. 56 Australia endocrine testing market, 2018 - 2030 (USD Million)
FIG. 57 Latin America endocrine testing market, 2018 - 2030 (USD Million)
FIG. 58 Brazil endocrine testing market, 2018 - 2030 (USD Million)
FIG. 59 Mexico endocrine testing market, 2018 - 2030 (USD Million)
FIG. 60 Middle East and Africa endocrine testing market, 2018 - 2030 (USD Million)
FIG. 61 South Africa endocrine testing market, 2018 - 2030 (USD Million)
FIG. 62 UAE endocrine testing market, 2018 - 2030 (USD Million)
FIG. 63 Saudi Arabia endocrine testing market, 2018 - 2030 (USD Million)
FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain-based sizing & forecasting
FIG. 6 Market formulation & validation
FIG. 7 Endocrine testing, market segmentation
FIG. 8 Market driver relevance analysis (Current & Future Impact)
FIG. 9 Market restraint relevance analysis (Current & Future Impact)
FIG. 10 Penetration & growth prospect mapping
FIG. 11 SWOT analysis, by factor (Political & Legal, Economic and Technological)
FIG. 12 Porter’s five forces analysis
FIG. 13 Market penetration vs growth prospect mapping, 2021
FIG. 14 Endocrine testing market test type outlook: Key takeaways
FIG. 15 Test type movement analysis, 2021 & 2030
FIG. 16 Global endocrine testing market, for Estradiol (E2) Test 2018 - 2030 (USD Million)
FIG. 17 Global endocrine testing market, for FSH test 2018 - 2030 (USD Million)
FIG. 18 Global endocrine testing market, for hCG test 2018 - 2030 (USD Million)
FIG. 19 Global endocrine testing market, for LH test 2018 - 2030 (USD Million)
FIG. 20 Global endocrine testing market, for DHEAS test 2018 - 2030 (USD Million)
FIG. 21 Global endocrine testing market, for progesterone test 2018 - 2030 (USD Million)
FIG. 22 Global endocrine testing market, for testerone test 2018 - 2030 (USD Million)
FIG. 23 Global endocrine testing market, for TSH test 2018 - 2030 (USD Million)
FIG. 24 Global endocrine testing market, for prolactin test 2018 - 2030 (USD Million)
FIG. 25 Global endocrine testing market, for cortisol test 2018 - 2030 (USD Million)
FIG. 26 Global endocrine testing market, for insulin test 2018 - 2030 (USD Million)
FIG. 27 Global endocrine testing market, for others 2018 - 2030 (USD Million)
FIG. 28 Endocrine testing market technology outlook: Key takeaways
FIG. 29 Technology movement analysis, 2021 & 2030
FIG. 30 Global endocrine testing market, for mass spectroscopy 2018 - 2030 (USD Million)
FIG. 31 Global endocrine testing market, for immunoassay 2018 - 2030 (USD Million)
FIG. 32 Global endocrine testing market, for chromatography 2018 - 2030 (USD Million)
FIG. 33 Global endocrine testing market, for nucleic acid based 2018 - 2030 (USD Million)
FIG. 34 Endocrine testing market end-users outlook: Key takeaways
FIG. 35 End-users movement analysis, 2021 & 2030
FIG. 36 Global endocrine testing market, for hospitals 2018 - 2030 (USD Million)
FIG. 37 Global endocrine testing market, for commercial laboratories 2018 - 2030 (USD Million)
FIG. 38 Global endocrine testing market, for ambulatory care centers 2018 - 2030 (USD Million)
FIG. 39 Global endocrine testing market, for others 2018 - 2030 (USD Million)
FIG. 40 Endocrine testing market regional outlook: Key takeaways
FIG. 41 Regional movement analysis, 2021 & 2030
FIG. 42 North America endocrine testing market, 2018 - 2030 (USD Million)
FIG. 43 U.S. endocrine testing market, 2018 - 2030 (USD Million)
FIG. 44 Canada endocrine testing market, 2018 - 2030 (USD Million)
FIG. 45 Europe endocrine testing market, 2018 - 2030 (USD Million)
FIG. 46 Germany endocrine testing market, 2018 - 2030 (USD Million)
FIG. 47 UK endocrine testing market, 2018 - 2030 (USD Million)
FIG. 48 France endocrine testing market, 2018 - 2030 (USD Million)
FIG. 49 Italy endocrine testing market, 2018 - 2030 (USD Million)
FIG. 50 Spain endocrine testing market, 2018 - 2030 (USD Million)
FIG. 51 Asia Pacific endocrine testing market, 2018 - 2030 (USD Million)
FIG. 52 China endocrine testing market, 2018 - 2030 (USD Million)
FIG. 53 Japan endocrine testing market, 2018 - 2030 (USD Million)
FIG. 54 India endocrine testing market, 2018 - 2030 (USD Million)
FIG. 55 South Korea endocrine testing market, 2018 - 2030 (USD Million)
FIG. 56 Australia endocrine testing market, 2018 - 2030 (USD Million)
FIG. 57 Latin America endocrine testing market, 2018 - 2030 (USD Million)
FIG. 58 Brazil endocrine testing market, 2018 - 2030 (USD Million)
FIG. 59 Mexico endocrine testing market, 2018 - 2030 (USD Million)
FIG. 60 Middle East and Africa endocrine testing market, 2018 - 2030 (USD Million)
FIG. 61 South Africa endocrine testing market, 2018 - 2030 (USD Million)
FIG. 62 UAE endocrine testing market, 2018 - 2030 (USD Million)
FIG. 63 Saudi Arabia endocrine testing market, 2018 - 2030 (USD Million)
